<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5820">
  <stage>Registered</stage>
  <submitdate>21/07/2015</submitdate>
  <approvaldate>21/07/2015</approvaldate>
  <nctid>NCT02509026</nctid>
  <trial_identification>
    <studytitle>Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA</studytitle>
    <scientifictitle>A Multicenter Open-label Study Of Etanercept Withdrawal And Retreatment In Subjects With Non-radiographic Axial Spondyloarthritis Who Achieved Adequate 24 Week Response</scientifictitle>
    <utrn />
    <trialacronym>RE-EMBARK</trialacronym>
    <secondaryid>2015-000541-24</secondaryid>
    <secondaryid>B1801381</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Spondylitis, Ankylosing</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Other inflammatory or immune system disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Other interventions - Etanercept

Experimental: Etanercept - etanercept 50 mg QW


Other interventions: Etanercept
50 mg subcutaneous, once weekly, 24 weeks

</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Estimate the proportion of subjects who flare - Estimate the proportion of subjects who flare within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>At any time up to 40 weeks following withdrawal of etanercept</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Measurement of the time to flare following withdrawal of etanercept - The time to flare following withdrawal of etanercept.</outcome>
      <timepoint>At any time up to 40 weeks following withdrawal of etanercept</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Occurrence of Ankylosing Spondylitis Disease Activity Score - C-Reactive Protein (ASDAS CRP) &lt;1.3 - Occurrence of ASDAS CRP &lt;1.3 within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>witin 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Occurrence of Assessment of Spondyloarthritis Society (ASAS) 20 - Occurrence of ASAS 20 within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Occurence of Assessment of Spondyloarthritis Society (ASAS) 40 - Occurrence of ASAS 40 within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Occurence of Assessment of Spondyloarthritis Society (ASAS) partial remission - Occurrence of ASAS partial remission within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Ankylosing Spondylitis Disease Activity Score (ASDAS) - ASDAS calculation within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Ankylosing Spondylitis Disease Activity Score (ASDAS) major improvement - Occurrence of ASDAS major improvement within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Ankylosing Spondylitis Disease Activity Score (ASDAS) clinically important improvement - Occurrence of ASDAS clinically important improvement within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Nocturnal Back Pain Visual Analog Scale (VAS) - Nocturnal back pain will be measured within 40 weeks following withdrawal</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Total Back Pain Visual Analog Scale (VAS) - Total back pain will be measured within 40 weeks following withdrawal</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Bath Ankylosing Functional Index (BASFI) - BASFI and its components will be measured within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>BathAnkylosing Spondylitis Disease Activity Index (BASDAI) - BASDAI and its components will be measured within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Bath Ankylosing Disease Activity Index (BASDAI) 50 - Occurrence of BASDAI 50 will be calculated within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measurement of High Sensitivity C-Reactive Protein (hsCRP) Laboratory Value - Measurement of hsCRP will be calculated within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>EuroQoL-5D Health Questionnaire (EQ-5D) - EQ-5D will be measured within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Short Form 36 (SF-36) Questionnaire - SF-36 will be measured within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Work Productivity and Activity Impairment (WPAI) Questionnaire - WPAI will be measured within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Magnetic Resonance Imaging (MRI) of the Sacroiliac Joint (SIJ) - MRI SIJ will be measured by SPARCC criteria within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Magnetic Resonance Imaging (MRI) spine - MRI spine will be measured by SPARCC criteria within 40 weeks following withdrawal of etanercept</outcome>
      <timepoint>within 40 weeks following withdrawal</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Measurement of the time to Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease - The time to ASDAS inactive disease will be estimated over 12 weeks following retreatment in subjects who flare.</outcome>
      <timepoint>following 12 weeks of retreatment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  diagnosis of axial SpA duration of symptoms &gt;3 months and &lt;5 years back pain with a
             less than favorable response to NSAIDs</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>49</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  radiological sacroiliitis previous treatment with TNF inhibitor, biologic,
             immunosuppressive</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>24/09/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>4/11/2019</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,QLD,SA,WA</recruitmentstate>
    <hospital>Genesis Research Services Pty Ltd - Broadmeadow</hospital>
    <hospital>Hunter Imaging Group - Cardiff</hospital>
    <hospital>Pacific Radiology - Maroochydore</hospital>
    <hospital>Rheumatology Research Unit - Maroochydore</hospital>
    <hospital>Benson Radiology - North Adelaide</hospital>
    <hospital>The Queen Elizabeth Hospital - Woodville South</hospital>
    <hospital>SKG Radiology Hollywood Hospital - Nedlands</hospital>
    <hospital>SKG Radiology Subiaco - Subiaco</hospital>
    <hospital>R.K. Will Pty Ltd - Victoria Park</hospital>
    <postcode>2292 - Broadmeadow</postcode>
    <postcode>2285 - Cardiff</postcode>
    <postcode>4558 - Maroochydore</postcode>
    <postcode>5006 - North Adelaide</postcode>
    <postcode>5011 - Woodville South</postcode>
    <postcode>6009 - Nedlands</postcode>
    <postcode>6008 - Subiaco</postcode>
    <postcode>6100 - Victoria Park</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Florida</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Illinois</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Oregon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Pennsylvania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Washington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>OVL</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Genk</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Antioquia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Cundinamarca</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czechia</country>
      <state>Praha 11</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czechia</country>
      <state>Praha 2</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czechia</country>
      <state>Uherske Hradiste</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>Helsinki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>Hyvinkaeae</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Nancy</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Paris</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Rennes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Toulouse cedex 9</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Vandoeuvre les Nancy</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Vandoeuvre-les-Nancy cedex</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Bavaria</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Charitéplatz 1</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Berlin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Chemnitz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Hamburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Herne</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Budapest</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Veszprem</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Amsterdam</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Leiden</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Bydgoszcz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Elblag</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Koscian</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Lublin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Poznan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Sochaczew</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Stalowa Wola</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Torun</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Warszawa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Wroclaw</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>A Coruna</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Santa Cruz de Tenerife</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Sevilla</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Gothenburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Malmo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Uppsala</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Kaohsiung</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taichung</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Pfizer</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to study the benefits and risks of etanercept withdrawal in
      patients who have achieved a significant clinical response.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02509026</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Pfizer CT.gov Call Center</name>
      <address>Pfizer</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Pfizer CT.gov Call Center</name>
      <address />
      <phone>1-800-718-1021</phone>
      <fax />
      <email>ClinicalTrials.gov_Inquiries@pfizer.com</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>